Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

News

Hollywood grinds to a halt as actors vote for historic strike

Published

on

Hollywood’s actors will go on strike, joining writers in the first industry-wide shutdown in 63 years.

While the impact of the writers’ strike has already been substantial, affecting film and TV production as well as events like awards shows and publicity functions, an actors’ strike would be even more significant.

This is primarily due to Sag-Aftra’s global influence: any production featuring a Hollywood actor would likely be forced to shut down or undergo extensive rescheduling as soon as a strike is declared.

The writers’ strike has resulted in the suspension of the majority of scripted TV shows in the US, as picket lines have effectively halted production activities.

Notable series such as The Last of Us, Blade Runner 2099, and The Mandalorian have already experienced delays. Furthermore, upcoming projects like the Spider-Man: No Way Home sequel and Disney’s Blade remake have been put on hold as scripts remain unfinished. Release dates for other productions, including Thunderbolts and Captain America: Brave New World, have been pushed back.

However, if US actors withdraw their participation, even productions with completed scripts will be unable to proceed, whether in the US, Europe, or elsewhere. TV shows like House of the Dragon, Andor, and Industry are expected to be affected, and the second season of Sharon Horgan’s Bad Sisters will likely face delays in commencing shooting. Even Doctor Who, which is now produced in collaboration with Disney+ streaming service, is at risk of being impacted by the strike.

Studio film productions, which typically have longer and more intricate schedules, will experience long-term consequences if filming isn’t completed on time. Noteworthy ongoing productions include Gladiator 2, directed by Ridley Scott and starring Paul Mescal, scheduled to shoot in Malta, Morocco, and the UK from June to October. Additionally, Mission: Impossible – Dead Reckoning Part Two, the sequel to Tom Cruise’s blockbuster, was set to finish filming this summer following promotional obligations for Part One.

Reports suggest that other studio productions, such as the fourth Bad Boys film, Beetlejuice 2, and the untitled Ghostbusters: Afterlife sequel, have completed filming. The second season of Amazon’s TV series The Lord of the Rings: The Rings of Power is also wrapped up.

Independent films

The situation becomes more complex for low-budget and independent films, as they may be able to seek waivers from Sag-Aftra to continue production. However, the uncertainty surrounding work permissions and crossing picket lines has led to significant financial instability in an already precarious industry. Even with a waiver and a finished script, productions cannot rely on crucial crew members’ participation since transportation union Teamsters and technicians’ union Iatse mostly refuse to cross the writers’ union picket lines.

Outside the realm of filmmaking, other high-profile events will likely be affected or canceled if the actors’ union declares a strike.

The London premiere of Christopher Nolan’s atom-bomb drama Oppenheimer has been rescheduled to allow the cast’s attendance.

Furthermore, the widely attended Comic-Con event in San Diego, scheduled for July 20-23, will likely face significant setbacks. Late summer releases like Teenage Mutant Ninja Turtles: Mutant Mayhem, Haunted Mansion, and Blue Beetle are also expected to curtail promotional activities. Major international film festivals like Venice and Toronto, held in late August and early September, should still be able to screen available films, but the participation of actors and red carpet events is now uncertain.

Continue Reading

News

Trump’s tariffs threaten Australia’s pharmaceutical industry prices

Trump’s tariffs may jeopardise Australia’s $1.1 billion pharmaceutical exports, risking essential medicine prices and healthcare quality.

Published

on

Trump’s tariffs may jeopardise Australia’s $1.1 billion pharmaceutical exports, risking essential medicine prices and healthcare quality.

In Short

Trump’s tariffs on steel and aluminium raise fears they could increase medicine prices in Australia, threatening its $1.1 billion pharmaceutical export industry. Prime Minister Albanese criticises the tariffs as unjustified but has ruled out retaliation, while industry experts warn against using health policies as trading leverage.

Fears have emerged that President Trump’s tariffs could adversely affect Australia’s pharmaceutical export industry, potentially raising medicine prices.

The Trump administration recently announced 25 per cent tariffs on steel and aluminium imports, sparking concern that Australia’s pharmaceutical exports, valued at approximately $1.1 billion in 2024, could face similar tariffs.

Prime Minister Anthony Albanese condemned the US tariff actions as unjustified and detrimental, indicating he would not retaliate with similar measures.

The pharmaceutical industry is a significant part of Australia’s economy and is critical to the $18 billion federal scheme that reduces essential medicine costs.

The US aims to protect its declining steel industry amidst increasing competition from Asia, particularly Canada, Brazil, and the EU.

US companies claim that Australia’s medicine pricing policies affect their earnings, raising concerns that they might push to reconsider the Pharmaceutical Benefits Scheme (PBS).

The PBS was instrumental in lowering the costs of 930 medications last year.

The Trump administration previously blamed the high costs of US medicines partly on foreign nations benefitting from US investment without contributing fairly.

Calls have been made for the Australian government to maintain a strong stance against US influence over its domestic health policies.

Albanese has ruled out retaliatory tariffs, highlighting the negative impact of trade wars on consumers.

Continue Reading

News

Economic anxiety leads to consumer spending cuts

Economic fears escalate as consumers and businesses cut spending, reflecting rising anxiety over inflation and potential recession.

Published

on

Economic fears escalate as consumers and businesses cut spending, reflecting rising anxiety over inflation and potential recession.

In Short

Consumer and business sentiment is declining due to economic uncertainty, leading many to cut back on spending. This shift is affecting both individual households and small businesses, causing widespread anxiety and caution in financial decisions.

Consumer and business sentiment is decreasing amid economic uncertainty, prompting many to cut back on expenses.

Discussions about economic issues, including layoffs and inflation, have increased, leading to reductions in discretionary spending. Research shows significant declines in consumer sentiment, with the University of Michigan reporting an 11% drop in March.

Many consumers are scaling back on non-essential purchases, evidenced by major airlines like Delta reducing their revenue forecasts. Walmart’s CEO remarked on observable consumer stress due to budgeting pressures.

Small business

Small businesses are also feeling the impact, with many reporting decreased sales and customer visits. Owners are experiencing heightened uncertainty, leading to precautionary measures.

Suresh Mallikaarjun, a retiree in Washington D.C., noted significant caution in his financial decisions, influenced by market volatility. Anecdotes of anxiety among consumers highlight the pervasive worry affecting spending behaviour.

As consumers tighten their budgets, the broader economic consequences could create a cycle of reduced growth, demonstrating the essential role of consumer confidence in economic performance.

Continue Reading

News

Aussie rookies show promise in Melbourne F1

Aussie rookies shine in wet race previews as reigning champion Verstappen struggles in 2025 F1 season opener.

Published

on

Aussie rookies shine in wet race previews as reigning champion Verstappen struggles in 2025 F1 season opener.

In Short

The 2025 Formula 1 season began with strong performances from Australian drivers, particularly Oscar Piastri, while reigning champion Max Verstappen struggled. Rain is expected on race day, intensifying the competitive midfield as teams prepare for potential challenges.

The 2025 Formula 1 season kicked off with promising performances from Australian drivers, but reigning champion Max Verstappen struggled. In second practice, Oscar Piastri finished second, ahead of teammate Lando Norris but behind Charles Leclerc from Ferrari.

Rain is expected on race day, and teams are challenged by contrasting qualifying conditions. Norris had the fastest time in FP1 but shifted to a more downforce-heavy setup for FP2 to prepare for the wet conditions.

Rookie Jack Doohan showed potential by outperforming veteran teammate Pierre Gasly in both practice sessions. Other drivers like Yuki Tsunoda and Isack Hadjar also made strong showings, while Carlos Sainz and Alex Albon showed promise for Williams.

Verstappen finished seventh in FP2, just ahead of Nico Hulkenberg and expressed the need for improvement. His new teammate Liam Lawson acknowledged the slow pace during their runs.

In Mercedes, George Russell reported similar issues with soft tires. Lewis Hamilton, now with Ferrari, is still adjusting to his new car, lagging behind Leclerc.

As the weekend progresses, the Australian fans hope for a strong showing from Piastri, viewed as a potential podium contender. The competitive nature of the midfield was evident, with several teams showcasing the possibility of breaking into the top ranks. Practice 3 and qualifying are set to occur before the race, with significant implications for the teams.

Continue Reading

Trending Now